2021 Q1 Form 10-Q Financial Statement

#000177045021000025 Filed on April 30, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $1.710B $1.860B
YoY Change -8.06% -14.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $448.0M $541.0M
YoY Change -17.19% -0.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $86.00M $94.00M
YoY Change -8.51% -20.34%
% of Gross Profit
Operating Expenses $448.0M $541.0M
YoY Change -17.19% -0.92%
Operating Profit
YoY Change
Interest Expense $52.00M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $53.00M -$5.000M
YoY Change -1160.0% -106.85%
Income Tax $14.00M -$1.000M
% Of Pretax Income 26.42%
Net Earnings $39.00M -$2.000M
YoY Change -2050.0% -101.5%
Net Earnings / Revenue 2.28% -0.11%
Basic Earnings Per Share $0.18 -$0.03
Diluted Earnings Per Share $0.18 -$0.03
COMMON SHARES
Basic Shares Outstanding 196.0M shares 212.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.379B $2.622B
Short-Term Investments
Other Short-Term Assets $262.0M $259.0M
YoY Change 1.16%
Inventory $841.0M $824.0M
Prepaid Expenses
Receivables $781.0M $1.060B
Other Receivables
Total Short-Term Assets $5.420B $5.977B
YoY Change -9.32%
LONG-TERM ASSETS
Property, Plant & Equipment $277.0M
YoY Change
Goodwill $4.075B $3.941B
YoY Change 3.4%
Intangibles $223.0M $263.0M
YoY Change -15.21%
Long-Term Investments
YoY Change
Other Assets $1.454B $1.309B
YoY Change 11.08%
Total Long-Term Assets $8.852B $8.807B
YoY Change 0.51%
TOTAL ASSETS
Total Short-Term Assets $5.420B $5.977B
Total Long-Term Assets $8.852B $8.807B
Total Assets $14.27B $14.78B
YoY Change -3.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $932.0M $1.122B
YoY Change -16.93%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.645B $3.373B
YoY Change -21.58%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $498.0M $530.0M
YoY Change -6.04%
Total Long-Term Liabilities $498.0M $530.0M
YoY Change -6.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.645B $3.373B
Total Long-Term Liabilities $498.0M $530.0M
Total Liabilities $8.629B $9.170B
YoY Change -5.9%
SHAREHOLDERS EQUITY
Retained Earnings $6.267B $6.252B
YoY Change 0.24%
Common Stock $2.655B $2.925B
YoY Change -9.23%
Preferred Stock
YoY Change
Treasury Stock (at cost) $162.0M $0.00
YoY Change
Treasury Stock Shares 6.704M shares 0.000 shares
Shareholders Equity $5.425B $5.393B
YoY Change
Total Liabilities & Shareholders Equity $14.27B $14.78B
YoY Change -3.46%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $39.00M -$2.000M
YoY Change -2050.0% -101.5%
Depreciation, Depletion And Amortization $86.00M $94.00M
YoY Change -8.51% -20.34%
Cash From Operating Activities $117.0M $173.0M
YoY Change -32.37% -23.45%
INVESTING ACTIVITIES
Capital Expenditures $8.000M $18.00M
YoY Change -55.56% 100.0%
Acquisitions $0.00 $193.0M
YoY Change -100.0% 4725.0%
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$17.00M -$214.0M
YoY Change -92.06% 1088.89%
FINANCING ACTIVITIES
Cash Dividend Paid $54.00M $58.00M
YoY Change -6.9% -6.45%
Common Stock Issuance & Retirement, Net $162.0M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $95.00M $0.00
YoY Change -100.0%
Cash From Financing Activities -$318.0M -$60.00M
YoY Change 430.0% -89.46%
NET CHANGE
Cash From Operating Activities $117.0M $173.0M
Cash From Investing Activities -$17.00M -$214.0M
Cash From Financing Activities -$318.0M -$60.00M
Net Change In Cash -$230.0M -$130.0M
YoY Change 76.92% -64.09%
FREE CASH FLOW
Cash From Operating Activities $117.0M $173.0M
Capital Expenditures $8.000M $18.00M
Free Cash Flow $109.0M $155.0M
YoY Change -29.68% -28.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001770450
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 xrx Finance Receivables Lease Portfolio Low Years
FinanceReceivablesLeasePortfolioLowYears
P2Y
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2021Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
XEROX HOLDINGS CORPORATION
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Entity File Number
EntityFileNumber
001-39013
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3933743
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 4505
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
201 Merritt 7
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Norwalk
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06851-1056
CY2021Q1 dei City Area Code
CityAreaCode
(203)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
849-5216
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $1 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
XRX
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
191947343 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1710000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1860000000 USD
CY2021Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
28000000 USD
CY2020Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
30000000 USD
CY2021Q1 xrx Research Development And Engineering Expenses
ResearchDevelopmentAndEngineeringExpenses
74000000 USD
CY2020Q1 xrx Research Development And Engineering Expenses
ResearchDevelopmentAndEngineeringExpenses
84000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
448000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
541000000 USD
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
17000000 USD
CY2020Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
41000000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 USD
CY2021Q1 xrx Business Acquisition Cost Acquired Entity Transaction Costs
BusinessAcquisitionCostAcquiredEntityTransactionCosts
0 USD
CY2020Q1 xrx Business Acquisition Cost Acquired Entity Transaction Costs
BusinessAcquisitionCostAcquiredEntityTransactionCosts
17000000 USD
CY2021Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
4000000 USD
CY2020Q1 xrx Other Expense Income Net
OtherExpenseIncomeNet
23000000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1657000000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
1865000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
39000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-2000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2000000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Profit Loss
ProfitLoss
39000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-2000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-51000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-197000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-7000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-55000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-54000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-138000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2379000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2625000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
68000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
69000000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
781000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
883000000 USD
CY2021Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4000000 USD
CY2020Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4000000 USD
CY2021Q1 xrx Billed Portion Of Finance Receivables Net
BilledPortionOfFinanceReceivablesNet
92000000 USD
CY2020Q4 xrx Billed Portion Of Finance Receivables Net
BilledPortionOfFinanceReceivablesNet
99000000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1065000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1082000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
841000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
843000000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
262000000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
251000000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
5420000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
5783000000 USD
CY2021Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
131000000 USD
CY2020Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
129000000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1920000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1984000000 USD
CY2021Q1 xrx Assets Leased To Others
AssetsLeasedToOthers
277000000 USD
CY2020Q4 xrx Assets Leased To Others
AssetsLeasedToOthers
296000000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
393000000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
407000000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
223000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
237000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4075000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4071000000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
510000000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
508000000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1454000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1455000000 USD
CY2021Q1 us-gaap Assets
Assets
14272000000 USD
CY2020Q4 us-gaap Assets
Assets
14741000000 USD
CY2021Q1 us-gaap Debt Current
DebtCurrent
678000000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
394000000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
932000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
983000000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
241000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
261000000 USD
CY2021Q1 xrx Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
794000000 USD
CY2020Q4 xrx Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
840000000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2645000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2478000000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
3674000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
4050000000 USD
CY2021Q1 xrx Pension And Other Benefit Liabilities
PensionAndOtherBenefitLiabilities
1473000000 USD
CY2020Q4 xrx Pension And Other Benefit Liabilities
PensionAndOtherBenefitLiabilities
1566000000 USD
CY2021Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
339000000 USD
CY2020Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
340000000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
498000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
497000000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
8629000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
8931000000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
199000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
198000000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2456000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2445000000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
162000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6267000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6281000000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3335000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3332000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5425000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5592000000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
4000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
4000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5429000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5596000000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14272000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14741000000 USD
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
198651000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
198386000 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6704000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
191947000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
198386000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
39000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-2000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94000000 USD
CY2021Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
20000000 USD
CY2020Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
80000000 USD
CY2021Q1 xrx Gain Loss On Sale Of Business And Property Plant And Equipment
GainLossOnSaleOfBusinessAndPropertyPlantAndEquipment
0 USD
CY2020Q1 xrx Gain Loss On Sale Of Business And Property Plant And Equipment
GainLossOnSaleOfBusinessAndPropertyPlantAndEquipment
1000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11000000 USD
CY2021Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
21000000 USD
CY2020Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
29000000 USD
CY2021Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
27000000 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
35000000 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
0 USD
CY2020Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
24000000 USD
CY2021Q1 us-gaap Pension Contributions
PensionContributions
35000000 USD
CY2020Q1 us-gaap Pension Contributions
PensionContributions
33000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-92000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-166000000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
126000000 USD
CY2021Q1 xrx Increase Decrease In Equipment On Operating Lease
IncreaseDecreaseInEquipmentOnOperatingLease
28000000 USD
CY2020Q1 xrx Increase Decrease In Equipment On Operating Lease
IncreaseDecreaseInEquipmentOnOperatingLease
32000000 USD
CY2021Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-37000000 USD
CY2020Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-93000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51000000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-36000000 USD
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-108000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-35000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-38000000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
6000000 USD
CY2020Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-10000000 USD
CY2021Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-3000000 USD
CY2020Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-8000000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-11000000 USD
CY2020Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
18000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173000000 USD
CY2021Q1 xrx Payments To Acquire Property Plant And Equipment And Software
PaymentsToAcquirePropertyPlantAndEquipmentAndSoftware
17000000 USD
CY2020Q1 xrx Payments To Acquire Property Plant And Equipment And Software
PaymentsToAcquirePropertyPlantAndEquipmentAndSoftware
23000000 USD
CY2021Q1 xrx Proceedsfromsalesofbusinessesandassets
Proceedsfromsalesofbusinessesandassets
0 USD
CY2020Q1 xrx Proceedsfromsalesofbusinessesandassets
Proceedsfromsalesofbusinessesandassets
2000000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
193000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-214000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2000000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
95000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
54000000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
58000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
162000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-318000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12000000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-29000000 USD
CY2021Q1 xrx Contract With Customer Liability Amortization Period
ContractWithCustomerLiabilityAmortizationPeriod
P30M
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-230000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-130000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2691000000 USD
CY2021Q1 xrx Incremental Direct Costs Of Obtaining A Contract
IncrementalDirectCostsOfObtainingAContract
13000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2795000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2461000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2665000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1710000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1860000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1710000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1860000000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
126000000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
130000000 USD
CY2020Q1 xrx Incremental Direct Costs Of Obtaining A Contract
IncrementalDirectCostsOfObtainingAContract
15000000 USD
CY2021Q1 xrx Capitalized Contract Costs Amortization Reported In Decrease Increase In Other Current And Long Term Assets
CapitalizedContractCostsAmortizationReportedInDecreaseIncreaseInOtherCurrentAndLongTermAssets
19000000 USD
CY2020Q1 xrx Capitalized Contract Costs Amortization Reported In Decrease Increase In Other Current And Long Term Assets
CapitalizedContractCostsAmortizationReportedInDecreaseIncreaseInOtherCurrentAndLongTermAssets
21000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
140000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
145000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2021Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
56000000 USD
CY2021Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
147000000 USD
CY2020Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
126000000 USD
CY2021Q1 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
55000000 USD
CY2020Q1 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
59000000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
67000000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
86000000 USD
CY2021Q1 us-gaap Variable Lease Income
VariableLeaseIncome
15000000 USD
CY2020Q1 us-gaap Variable Lease Income
VariableLeaseIncome
22000000 USD
CY2021Q1 us-gaap Lease Income
LeaseIncome
284000000 USD
CY2020Q1 us-gaap Lease Income
LeaseIncome
293000000 USD
CY2020Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
43000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2379000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2625000000 USD
CY2021Q1 xrx Tax And Labor Litigation Deposits In Brazil
TaxAndLaborLitigationDepositsInBrazil
38000000 USD
CY2020Q4 xrx Tax And Labor Litigation Deposits In Brazil
TaxAndLaborLitigationDepositsInBrazil
42000000 USD
CY2021Q1 us-gaap Receivables Held For Sale Amount
ReceivablesHeldForSaleAmount
43000000 USD
CY2020Q4 us-gaap Receivables Held For Sale Amount
ReceivablesHeldForSaleAmount
22000000 USD
CY2021Q1 xrx Other Restricted Cash
OtherRestrictedCash
1000000 USD
CY2020Q4 xrx Other Restricted Cash
OtherRestrictedCash
2000000 USD
CY2021Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
82000000 USD
CY2020Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
66000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2461000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2691000000 USD
CY2021Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
82000000 USD
CY2020Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
66000000 USD
CY2021Q1 xrx Receivable Credit Loss Expense Reversal
ReceivableCreditLossExpenseReversal
11000000 USD
CY2020Q1 xrx Receivable Credit Loss Expense Reversal
ReceivableCreditLossExpenseReversal
74000000 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
9000000 USD
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
6000000 USD
CY2021Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
2000000 USD
CY2020Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
2000000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
19000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
21000000 USD
CY2021Q1 xrx Depreciation Expense Assets Leased To Others
DepreciationExpenseAssetsLeasedToOthers
42000000 USD
CY2020Q1 xrx Depreciation Expense Assets Leased To Others
DepreciationExpenseAssetsLeasedToOthers
51000000 USD
CY2021Q1 xrx Amortization Of Internal Use Software
AmortizationOfInternalUseSoftware
10000000 USD
CY2020Q1 xrx Amortization Of Internal Use Software
AmortizationOfInternalUseSoftware
11000000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
20000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
22000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000000 USD
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
9000000 USD
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
5000000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
50000000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54000000 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4000000 USD
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4000000 USD
CY2021Q1 xrx Payments For Repurchase Of Common Stock Share Based Compensation
PaymentsForRepurchaseOfCommonStockShareBasedCompensation
4000000 USD
CY2020Q1 xrx Payments For Repurchase Of Common Stock Share Based Compensation
PaymentsForRepurchaseOfCommonStockShareBasedCompensation
7000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
69000000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55000000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000000 USD
CY2021Q1 xrx Accounts Receivable Allowance For Credit Loss Recoveries And Other
AccountsReceivableAllowanceForCreditLossRecoveriesAndOther
0 USD
CY2020Q1 xrx Accounts Receivable Allowance For Credit Loss Recoveries And Other
AccountsReceivableAllowanceForCreditLossRecoveriesAndOther
1000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
68000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
60000000 USD
CY2021Q1 xrx Remaining Account Receivable Sold And Derecognized
RemainingAccountReceivableSoldAndDerecognized
93000000 USD
CY2020Q4 xrx Remaining Account Receivable Sold And Derecognized
RemainingAccountReceivableSoldAndDerecognized
136000000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
3596000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
3691000000 USD
CY2021Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
384000000 USD
CY2020Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
393000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3212000000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3298000000 USD
CY2021Q1 xrx Finance Receivables Residual Values
FinanceReceivablesResidualValues
0 USD
CY2020Q4 xrx Finance Receivables Residual Values
FinanceReceivablesResidualValues
0 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
135000000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
133000000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3077000000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3165000000 USD
CY2021Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
92000000 USD
CY2020Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
99000000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1065000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1082000000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1920000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1984000000 USD
CY2021Q1 xrx Finance Lease Portfolio Average Maturity High Years
FinanceLeasePortfolioAverageMaturityHighYears
P3Y
CY2020Q1 xrx Reserves As A Percentage Of Financing Receivables
ReservesAsAPercentageOfFinancingReceivables
0.04
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
133000000 USD
CY2021Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
6000000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
3000000 USD
CY2021Q1 xrx Financing Receivable Allowance For Credit Loss Recoveries And Other
FinancingReceivableAllowanceForCreditLossRecoveriesAndOther
-1000000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
135000000 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3212000000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
89000000 USD
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
66000000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
8000000 USD
CY2020Q1 xrx Financing Receivable Allowance For Credit Loss Recoveries And Other
FinancingReceivableAllowanceForCreditLossRecoveriesAndOther
-1000000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
146000000 USD
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3287000000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
135000000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
146000000 USD
CY2021Q1 xrx Loss Rates Of Customers With Investment Grade Credit Quality
LossRatesOfCustomersWithInvestmentGradeCreditQuality
0.01
CY2021Q1 xrx Loss Rates Of Customers With Non Investment Grade Credit Quality Low Range
LossRatesOfCustomersWithNonInvestmentGradeCreditQualityLowRange
0.02
CY2021Q1 xrx Loss Rates Of Customers With Non Investment Grade Credit Quality High Range
LossRatesOfCustomersWithNonInvestmentGradeCreditQualityHighRange
0.05
CY2021Q1 xrx Loss Rate Of Customers With Substandard Doubtful Credit Quality Low
LossRateOfCustomersWithSubstandardDoubtfulCreditQualityLow
0.07
CY2021Q1 xrx Loss Rate Of Customers With Substandard Doubtful Credit Quality High
LossRateOfCustomersWithSubstandardDoubtfulCreditQualityHigh
0.10
CY2021Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
337000000 USD
CY2021Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
1058000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
901000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
574000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
262000000 USD
CY2021Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
80000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3212000000 USD
CY2020Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
1140000000 USD
CY2020Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
1005000000 USD
CY2020Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
680000000 USD
CY2020Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
337000000 USD
CY2020Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
116000000 USD
CY2020Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
20000000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3298000000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3212000000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3298000000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
697000000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
707000000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
48000000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
43000000 USD
CY2021Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
96000000 USD
CY2020Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
93000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
841000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
843000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1332000000 USD
CY2020Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
22000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1376000000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1055000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1080000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
277000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
296000000 USD
CY2021Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
15000000 USD
CY2021Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12Y
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
27000000 USD
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
28000000 USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000000 USD
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
12000000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
12000000 USD
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
1000000 USD
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
0 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
43000000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
45000000 USD
CY2021Q1 xrx Lessee Operating Lease Additional Leases Not Yet Commenced
LesseeOperatingLeaseAdditionalLeasesNotYetCommenced
1 lease
CY2021Q1 xrx Lessee Operating Lease Liability Not Yet Commenced Amount
LesseeOperatingLeaseLiabilityNotYetCommencedAmount
8000000 USD
CY2021Q1 xrx Lessee Operating Lease Right Of Use Asset Lease Not Yet Commenced Amount
LesseeOperatingLeaseRightOfUseAssetLeaseNotYetCommencedAmount
8000000 USD
CY2021Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P6Y
CY2021Q1 xrx Lessee Operating Lease Lease Not Yet Commenced Number Of Options To Terminate
LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToTerminate
1 option
CY2021Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Renewal Term1
LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1
P3Y
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
287000000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
310000000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79000000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
83000000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231000000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250000000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
310000000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
333000000 USD
CY2021Q1 xrx Restructuring Net Current Period Charges
RestructuringNetCurrentPeriodCharges
21000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
350 employee
CY2021Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-4000000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
82000000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
25000000 USD
CY2021Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-4000000 USD
CY2021Q1 xrx Restructuring Net Current Period Charges
RestructuringNetCurrentPeriodCharges
21000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
40000000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
63000000 USD
CY2021Q1 xrx Leased Right Of Use Asset Write Off
LeasedRightOfUseAssetWriteOff
1000000 USD
CY2021Q1 xrx Owned Asset Write Off
OwnedAssetWriteOff
9000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
40000000 USD
CY2020Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
35000000 USD
CY2021Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
13000000 USD
CY2020Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
0 USD
CY2021Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
27000000 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
35000000 USD
CY2021Q1 xrx Related Restructuring Costs
RelatedRestructuringCosts
-4000000 USD
CY2020Q1 xrx Related Restructuring Costs
RelatedRestructuringCosts
12000000 USD
CY2021Q1 xrx Related Restructuring Costs
RelatedRestructuringCosts
-4000000 USD
CY2021Q1 xrx Restructuring Related Reserve
RestructuringRelatedReserve
13000000 USD
CY2020Q4 xrx Restructuring Related Reserve
RestructuringRelatedReserve
21000000 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10000000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
52000000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
51000000 USD
CY2021Q1 xrx Interest Income
InterestIncome
56000000 USD
CY2020Q1 xrx Interest Income
InterestIncome
67000000 USD
CY2021Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
968000000 USD
CY2020Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1161000000 USD
CY2021Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Three Months
AverageMaturityOfForeignExchangeHedgingContractsWithinThreeMonths
0.78
CY2021Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Three And Six Months
AverageMaturityOfForeignExchangeHedgingContractsWithinThreeAndSixMonths
0.11
CY2021Q1 xrx Average Maturity Of Foreign Exchange Hedging Contracts Within Six And Twelve Months
AverageMaturityOfForeignExchangeHedgingContractsWithinSixAndTwelveMonths
0.11
CY2020Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
2000000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
4000000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
7000000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
14000000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
5000000 USD
CY2021Q1 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-10000000 USD
CY2021Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-5000000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5596000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36000000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49000000 USD
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4000000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12000000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
162000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5429000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5594000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-140000000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
54000000 USD
CY2020Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 USD
CY2020Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5400000000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2021Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
20.00
CY2020Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
20.00
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
39000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2000000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4000000 USD
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4000000 USD
CY2021Q1 xrx Adjusted Net Income Availableto Common Shareholders Common
AdjustedNetIncomeAvailabletoCommonShareholdersCommon
35000000 USD
CY2020Q1 xrx Adjusted Net Income Availableto Common Shareholders Common
AdjustedNetIncomeAvailabletoCommonShareholdersCommon
-6000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195985000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212750000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
39000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2000000 USD
CY2021Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4000000 USD
CY2020Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4000000 USD
CY2021Q1 xrx Adjusted Net Income Loss Availableto Common Shareholders Diluted
AdjustedNetIncomeLossAvailabletoCommonShareholdersDiluted
35000000 USD
CY2020Q1 xrx Adjusted Net Income Loss Availableto Common Shareholders Diluted
AdjustedNetIncomeLossAvailabletoCommonShareholdersDiluted
-6000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195985000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212750000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
198166000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
212750000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12762000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14069000 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2021Q1 xrx Number Of Requests For Arbitration
NumberOfRequestsForArbitration
2 request

Files In Submission

Name View Source Status
0001770450-21-000025-index-headers.html Edgar Link pending
0001770450-21-000025-index.html Edgar Link pending
0001770450-21-000025.txt Edgar Link pending
0001770450-21-000025-xbrl.zip Edgar Link pending
ex1010-dsuawardsummaryxxhc.htm Edgar Link pending
ex1011-rsuawardagreementxx.htm Edgar Link pending
ex1012-rsuawardsummaryxxhc.htm Edgar Link pending
ex109-dsuawardagreementxxh.htm Edgar Link pending
ex31a1-xeroxholdingsx33121.htm Edgar Link pending
ex31a2-xeroxcorpx33121ceoc.htm Edgar Link pending
ex31b1-xeroxholdingsx33121.htm Edgar Link pending
ex31b2-xeroxcorpx33121cfoc.htm Edgar Link pending
ex32a-xeroxholdingsx33121x.htm Edgar Link pending
ex32b-xeroxcorpx33121xsoxc.htm Edgar Link pending
ex41-registrationrightsagr.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xrx-20210331.htm Edgar Link pending
xrx-20210331.xsd Edgar Link pending
xrx-20210331_cal.xml Edgar Link unprocessable
xrx-20210331_def.xml Edgar Link unprocessable
xrx-20210331_g1.jpg Edgar Link pending
xrx-20210331_htm.xml Edgar Link completed
xrx-20210331_lab.xml Edgar Link unprocessable
xrx-20210331_pre.xml Edgar Link unprocessable